title: The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation.
abstract: The monoamine serotonin (5-HT), a well-known neurotransmitter, is also important in peripheral tissues. Several studies have suggested that 5-HT is involved in bone metabolism. Starting from our original observation of increased 5-HT(2B) receptor (5-HT(2B)R) expression during in vitro osteoblast differentiation, we investigated a putative bone phenotype in vivo in 5-HT(2B)R knockout mice. Of interest, 5-HT(2B)R mutant female mice displayed reduced bone density that was significant from age 4 months and had intensified by 12 and 18 months. This histomorphometrically confirmed osteopenia seems to be due to reduced bone formation because 1) the alkaline phosphatase-positive colony-forming unit capacity of bone marrow precursors was markedly reduced in the 5-HT(2B)R mutant mice from 4 to 12 months of age, 2) ex vivo primary osteoblasts from mutant mice exhibited reduced proliferation and delayed differentiation, and 3) calcium incorporation was markedly reduced in osteoblasts after 5-HT(2B)R depletion (produced genetically or by pharmacological inactivation). These findings support the hypothesis that the 5-HT(2B)R receptor facilitates osteoblast recruitment and proliferation and that its absence leads to osteopenia that worsens with age. We show here, for the first time, that the 5-HT(2B)R receptor is a physiological mediator of 5-HT in bone formation and, potentially, in the onset of osteoporosis in aging women.
authors.affiliation: INSERM U606 Hôpital Lariboisière, 2 rue Ambroise Paré, 75475 Paris cedex 10, France.
authors.forename: C
authors.initials: C
authors.lastname: Collet
authors.forename: C
authors.initials: C
authors.lastname: Schiltz
authors.forename: V
authors.initials: V
authors.lastname: Geoffroy
authors.forename: L
authors.initials: L
authors.lastname: Maroteaux
authors.forename: J-M
authors.initials: JM
authors.lastname: Launay
authors.forename: M-C
authors.initials: MC
authors.lastname: de Vernejoul
mesh_terms: D000375:Aging / Q000502:physiology; D000818:Animals; D015519:Bone Density / Q000502:physiology*; D001851:Bone Diseases, Metabolic / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation; D049109:Cell Proliferation; D002478:Cells, Cultured; D005260:Female; D005786:Gene Expression Regulation; D051379:Mice; D018345:Mice, Knockout; D010006:Osteoblasts / Q000166:cytology* / Q000378:metabolism*; D011985:Receptors, Serotonin / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism*
chemical_list: D011985:Receptors, Serotonin; C078730:serotonin 5 receptor